This section shows a general overview of information for the selected study (COSU identifier) or publication (COSP identifier). Studies may have been performed by the Sanger Institute Cancer Genome Project, or imported from the ICGC/TCGA. You can see more information on the help pages.
- Aristolochic acid in the etiology of renal cell carcinoma.
- Paper ID
- Ludwig Center for Cancer Genetics and Therapeutics and The Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016
PMID: 27555084 (view at PubMed or Europe PMC)
- Background: Aristolochia species used in the practice of traditional herbal medicine contain aristolochic acid (AA), an established human carcinogen contributing to urothelial carcinomas of the upper urinary tract. AA binds covalently to genomic DNA, forming aristolactam (AL)-DNA adducts. We here investigated whether AA is also an etiologic factor in clear cell renal cell carcinoma (ccRCC).Methods: We conducted a population-based case-control study to investigate the linkage between Aristolochia prescription history, cumulative AA consumption, and ccRCC incidence in Taiwan (5,709 cases and 22,836 matched controls). The presence and level of mutagenic dA-AL-I adducts were determined in the kidney DNA of 51 Taiwanese ccRCC patients. The whole exome sequences of ccRCC tumors from ten Taiwanese ccRCC pateints with prior exposure to AA were determined.Results: Cumulative ingestion of more than 250 milligrams of AA increased risk of ccRCC (OR 1.25) and we detected dA-AL-I adducts in 76% of Taiwanese ccRCC patients. Further, the distinctive AA-mutational signature was evident in six of ten sequenced ccRCC exomes from Taiwanese patients.Conclusions: This study strongly suggests that AA contributes to the etiology of certain renal cell carcinomas.Impact: The present study offers compelling evidence implicating AA in a significant fraction of the RCC arising in Taiwan and illustrates the power of integrating epidemiological, molecular and genetic data in the investigation of cancer etiology.
- Paper Status
- Genes Analysed
- Mutated Samples
- Total No. of Samples